Aberrant Expression Notch1 and Asb2 mRNA in Bone Marrow from Patients with P210(+) Chronic Myeloid Leukemia.
- Author:
Ya-Yun DENG
1
;
Wei WU
1
;
Ping-An ZHANG
2
Author Information
- Publication Type:Journal Article
- MeSH: Bone Marrow; metabolism; Case-Control Studies; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; genetics; metabolism; RNA, Messenger; genetics; metabolism; Receptor, Notch1; genetics; metabolism; Signal Transduction; Suppressor of Cytokine Signaling Proteins; genetics; metabolism
- From: Journal of Experimental Hematology 2016;24(3):667-671
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the mRNA expression level of Notch1 and ASB2 in bone marrow mononuclear cells of patients with P210(+) chronic myeloid leukemia and the correlation between Notch signaling pathway and ubiquitination in chronic myeloid leukemia, so as to provide the valuable information for investigating the pathogenesis of chronic myeloid leukemia and clinical treatment.
METHODSBone marrow was collected from 32 patients with newly diagnosed chronic myeloid leukemia and 34 non-hematopathic and healthy individuals (control group), respectively. The mRNA expression levels of Notch1 and ASB2 were detected by real-time quantitative PCR.
RESULTSThe expression of Notch1 mRNA in CML patients were significantly different from that of healthy individuals group (t=36.3, P<0.01), which was 337.8 times of the healthy individuals. Moreover, the expression level of ASB2 mRNA in CML group was significantly higher than that in healthy individuals (t=19.4, P<0.01). The mRNA expression of Notch1 and ASB2 gene was positive correlation (r=0.504, P<0.01).
CONCLUSIONThe aberrant expression of Notch1 and Asb2 exists in patients with P210 positive CML, which may be involved in incidence and development of CML.
